ライフサイエンスコーパス: three-vessel disease

1 no or single-vessel disease versus 50.8% for three-vessel disease.

2 rategy, on outcomes of patients with de novo three-vessel disease.

3 3.1+/-9.1 years, 29% were women, and 83% had three-vessel disease.

4 (or rules out) left main coronary artery or three-vessel disease.

5 Among patients with three-vessel disease, 153 (28%) of 546 had died after PC

6 up to 10-year survival of 1800 patients with three-vessel disease (3VD) and/or left main coronary art

7 58,498, P<0.05), but not among patients with three-vessel disease ($60,918 vs. $59,430).

8 myocardial infarction both for patients with three-vessel disease and for patients with two-vessel di

9 In patients with three-vessel disease and reduced LV function (ejection f

10 y, CABG decreases mortality in patients with three-vessel disease and two-vessel disease involving th

11 In patients with three-vessel disease and/or left main disease, selecting

12 ignificant survival benefit in patients with three-vessel disease, but not in patients with left main

13 Also, patients with three-vessel disease had a statistically significantly l

14 r classified into groups with one-, two-, or three-vessel disease if any of the three coronary arteri

15 TAX II PCI strategy in patients with de novo three-vessel disease led to improved and durable clinica

16 iographic high risk predictors (left main or three-vessel disease or ejection fraction <45%) were pre

17 he basis of previous evidence: disease type (three-vessel disease or left main coronary artery diseas

18 ry disease was defined as left main disease, three-vessel disease or two-vessel disease with involvem

19 symptomatic patients with left-main disease, three-vessel disease, or two-vessel disease including pr

20 ncrease in heart weight with one-, two-, and three-vessel disease (P = .01).

21 compared with 75% for two-vessel and 27% for three-vessel disease (p = 0.009).

22 two-vessel disease, and 953.35+/-1023.45 in three-vessel disease (p<0.001).

23 d heavier; more likely to be female and have three-vessel disease, prior coronary artery bypass graft

24 e was significantly higher in the group with three-vessel disease than in the other groups (those wit

25 e was significantly higher in the group with three-vessel disease than in the other groups combined (

26 Seven-year survival among patients with three-vessel disease undergoing PTCA and CABG (n = 754)

27 disease of the left main coronary artery or three-vessel disease were 100 percent (95 percent confid

28 adjusted odds ratios for the development of three-vessel disease were 2.80 (95% confidence interval

29 y artery disease and for left main artery or three-vessel disease were 81 percent (95 percent confide

30 prior myocardial infarction and presence of three-vessel disease were independent predictors of long

31 Among patients with three-vessel disease who underwent CABG, as compared wit

32 ce interval, 0.56 to 0.74) for patients with three-vessel disease with involvement of the proximal le

33 t main coronary artery disease or those with three-vessel disease with left ventricular impairment.

34 t main lesions on angiography, and 53.4% had three-vessel disease, with higher rates of both for thos